Enrollment completed across 18 clinical sites with 40+ investigators in the US, Canada, and New Zealand If the GPX ...
MANCHESTER, UNITED KINGDOM, January 7, 2026 /EINPresswire.com/ — Manchester-based activist rock band Alternative Influence ...
1d
Bonk, Inc. Bolstered Q4 Balance Sheet with $1 Million Strategic Injection from BONK.fun Operations
Company Successfully Executed Distribution of $500,000 in Cash and $500,000 in BONK Digital Assets Prior to Year-End; ...
NEW YORK, NY, NY, UNITED STATES, January 7, 2026 /EINPresswire.com/ — Ouros Jewels has announced the launch of its ...
A Milestone Transaction Reflecting Deep Sector Knowledge and Strategic Execution TULSA, OK, UNITED STATES, January 7, ...
Fluidx Medical Technology, Inc. announced the completion of patient enrollment in the investigational device exemption (IDE) piv ...
Company Achieves Clinical Development Milestones in 2025, Advances Program for Future Scale Up and Studies AUSTIN, Texas, Jan. 7, 2026 /PRNewswire/ -- Genprex, Inc.
Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing ...
Genprex Inc. has released preliminary in vivo proof-of-concept data for GPX-002, the company’s diabetes gene therapy drug candidate, in a nonhuman primate (NHP) model of type 2 diabetes and in a mouse ...
Preliminary Preclinical Data Demonstrates In Vivo Proof-of-Concept for Novel Diabetes Gene Therapy in Type 2 Diabetic Non-Human Primates GPX-002 Rejuvenated Exhausted ...
Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing ...
Hosted on MSN
Foot to armpit
What happens to your personal loan if you die before repaying it? Here’s what banks don’t clearly explain Madhuri Dixit recalls her first 'rubbery' meal for husband Shriram Nene: 'He was like…' 'Fully ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback